H.R. 8930 · 119th Congress · Government Operations and Politics
Federal Biotechnology Workforce Assessment Act
- IntroducedMay 20, 2026 Done
- CommitteeReferred to Oversight and Government Reform Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.Who lobbies on it
1 organization · 1 filing · Q2 2026–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Biotechnology Innovation Organization
1 of 2 quarters
“…H.R.8930: Federal Biotechnology Workforce Assessment Act ---H.R.8938: Biotechnology Workforce Alignment Act of 2026 Foreign Drug Data Protection Law ---Implementation of BIOSECURE Act Generic Drug Entry ---S.43/H.R.6485: Skinny Labels, Big Savings Act ---S.1095: Stop STALLING Act ---Generic Drug Application Review…”
$6.5M lobbying spend in 2026 to date, all issuesQ3 2026 filing
Organizations that named H.R. 8930 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- May 20, 2026Referred to the House Committee on Oversight and Government Reform.
- May 20, 2026Introduced in House